Nkarta, Inc. Collaboration Agreements
5 Contracts & Agreements
- Amendment No. 4 to the Research Collaboration Agreement, dated May 2, 2024, by and between Nkarta, Inc. and CRISPR Therapeutics AG (Filed With SEC on August 13, 2024)
- Amendment No. 3 to the Research Collaboration Agreement, dated April 3, 2024, by and between Nkarta, Inc. and CRISPR Therapeutics AG (Filed With SEC on August 13, 2024)
- Amendment No. 2 to the Research Collaboration Agreement, dated March 8, 2023, by and between Nkarta, Inc. and CRISPR Therapeutics AG (Filed With SEC on May 11, 2023)
- Amendment No. 1 to the Research Collaboration Agreement, dated May 4, 2022, by and between Nkarta, Inc. and CRISPR Therapeutics AG (Filed With SEC on May 12, 2022)
- Research Collaboration Agreement, dated May 5, 2021, by and between Nkarta, Inc. and CRISPR Therapeutics AG (Filed With SEC on August 12, 2021)
